| [1] |
Rodeghiero F，Stasi R，Gernsheimer T，et al．Standardization of terminology，definitions and outcome criteria in immune thrombocytopenic purpura of adults and children：report from an international working group[J]．Blood，2009，113(11)，2389-2393．
|
| [2] |
Matzdorff A，Neufeld EJ，Roganovic J．To treat or not to treat-from guidelines to individualized patient management[J]．Semin Hematol，2013，50(Suppl 1):S12-S17．
|
| [3] |
中华医学会儿科学分会血液学组，中华儿科杂志编辑委员会．儿童原发性免疫性血小板减少症诊疗建议[J]．中华儿科杂志，2013，51(3):382-384．
|
| [4] |
Kuhne T，Imbach P，Bolton-Maggs PH，et al．Intercontinental Childhood ITP Study Group．Newly diagnosed idiopathic thrombocytopenic purpura in childhood：an observational study[J]．Lancet，2001，358(9299):2122-2125．
|
| [5] |
Wilson DB．Acquired platelet defects／/Orkin Sh．Hematology of infancy and childhood [M]．Philadepha，PA：Saunders Elsevier，2009:1553-1590．
|
| [6] |
Rosthj S，Hedlund-Treutiger I，Rajantie J，et al，NOPHO ITP Working Group．Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children：a prospective Nordic study of an unselected cohort[J]．J Pediatr，2003，143(3):302-307．
|
| [7] |
Kühne T，Buchanan GR，Zimmerman S，et al．Intercontinental Childhood ITP Study Group，Intercontinental Childhood ITP Study Group．A prospective comparative study of 2 540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP)from the Intercontinental Childhood ITP Study Group[J]．J Pediatr，2003，143(5):605-608．
|
| [8] |
Neunert CE，Buchanan GR，Imbach P，et al．Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura[J]．Blood，2008，112(10):4003-4008．
|
| [9] |
Neunert C，Lim W，Crowther M，et al．American Society of Hematology．The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]．Blood，2011，117(16):4190-4207．
|
| [10] |
Cecinati V，Principi N，Brescia L，et al．Vaccine administration and the development of immune thrombocytopenic purpura in children[J]．Hum Vaccin Immunother，2013，9(5):1158-1162．
|
| [11] |
O' Leary ST，Jason M．The risk of immune thrombocytopenic purpura after vaccination in children and adolescents [J]． Pediatrics，2012，129(2):248-255．
|
| [12] |
Hsieh YL，Lin LH．Thrombocytopenic purpura following vaccination in early childhood：experience of a medical center in the past 2 decades[J]．J Chin Med Assoc，2010，73(12):634-637．
|
| [13] |
George JN，Woolf SH，Raskob GE．Idiopathic thrombocytopenic purpura：a guideline for diagnosis and management of children and adults．American Society of Hematology[J]．Ann Med，1998，30(1):38-44．
|
| [14] |
Nugent DJ．Childhood immune thrombocytopenic purpura [J]． Blood Rev，2002，16(1):27-29．
|
| [15] |
Neunert CE，Buchanan GR，Imbach P，et al．Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura[J]．Blood，2008，112(10):4003-4008．
|
| [16] |
So MY，Li CH，Lee AC，et al．Intracranial hemorrhage among Chinese children with immune thrombocytopenia in a Hong Kong regional hospital[J]．Hong Kong Med J，2013，19(2):129-134．
|
| [17] |
Abshire T．Childhood ITP：can we venture below 20 000？[J]． Blood，2008，112(10):3918-3919．
|
| [18] |
Page KL，Psaila B，Provan D，et al．The immune thrombocytopenic purpura (ITP)bleeding score：assessment of bleeding in patients with ITP[J]．Br J Haematol，2007，138(2):245-248．
|
| [19] |
Buchanan GR，Adix L．Grading of hemorrhage in children with idiopathic thrombocytopenic purpura[J]．J Pediatr，2002，141(5):683-688．
|
| [20] |
Klaassen RJ，Blanchette V，Burke TA，et al．Quality of life in childhood immunethrombocytopenia：international validation of the kids' ITP tools[J]．Pediatr Blood Cancer，2013，60(1):95-100．
|
| [21] |
Klaassen RJ，Mathias SD，Buchanan G，et al．Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL)and parental burden in immune thrombocytopenia (ITP)[J]．Pediatr Blood Cancer，2012，58(3):395-398．
|
| [22] |
Portielje JE，Westendorp RG，Kluin-Nelemans HC，et al． Morbidity and mortality in adults with idiopathic thrombocytopenic purpura[J]．Blood，2001，97(9):2549-2554．
|
| [23] |
Braga JAP，Loggetto SR．Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents：Associacão Brasileira de Hematologia，Hemoterapia e Terapia Celular Guidelines Project：Associacão Médica Brasileira：2012 [J]．Rev Bras Hematol Hemoter，2013，35(5):358-365．
|
| [24] |
Bekker E，Rosthøj S．Successful implementation of a watchful waiting strategy for children with immune thrombocytopenia[J]． Dan Med Bull，2011，58(4):A4252-A4256．
|
| [25] |
Provan D，Stasi R，Newland AC，et al．International consensus report on the investigation and management of primary immune thrombocytopenia[J]．Blood，2010，115(2):168-186．
|
| [26] |
D'Orazio JA，Neely J，Farhoudi N．ITP in children：pathophysiology and current treatment approaches[J]．J Pediatr Hematol Oncol，2013，35(1):1-13．
|
| [27] |
Naithani R，Kumar R，Mahapatra M，et al．Is it safe to avoid bone marrow examination in suspected ITP？[J]．Pediatr Hematol Oncol，2007，24(3):205-207．
|
| [28] |
Shahgholi E，Vosough P，Sotoudeh K，et al．Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura[J]．Indian J Pediatr，2008，75(12):1231-1235．
|
| [29] |
Stasi R．Pathophysiology and therapeutic options in primary immune thrombocytopenia[J]．Blood Transfus，2011，9(3):262-273．
|
| [30] |
Generali JA，Cada DJ．Dexamethasone：idiopathic thrombocytopenic purpura in children and adolescents[J]．Hosp Pharm，2013，48(2):108-110．
|
| [31] |
Cheng Y，Wong RS，Soo YO，et al．Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone[J]．N Engl J Med，2003，349(9):831-836．
|
| [32] |
Borst F，Keuning JJ，van Hulsteijn H，et al．High-dose dexamethasone as a first and second-line treatment of idiopathic thrombocytopenic purpura in adults[J]．Ann Hematol，2004，83(12):764-768．
|
| [33] |
Kumar S，Benseler SM，Kirby-Allen M，et al．B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus[J]．Pediatrics，2009，123(1):e159-e163．
|
| [34] |
Mokhtar GM，Tantawy AA，El Sherif NH．Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia[J]．Platelets，2012，23(4):264-273．
|
| [35] |
Vilaplana VE，Aragonés JH，Fernández-Llamazares CM，et al． Useof romiplostim for primary immune thrombocytopenia in children[J]．Pediatr Hematol Oncol，2012，29(2):197-205．
|
| [36] |
HanJ J，Baek SK，Lee JJ，et al．Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy[J]．Korean J Hematol，2010，45(3):197-204．
|
| [37] |
Blanchette V，Bolton-Maggs P．Childhood immune thrombocytopenic purpura：diagnosis and management [J]． Hematol Oncol Clin North Am，2010，24(1):249-273．
|